ATM and neoplasm: Synthetic lethal interactions between the FA pathway and other DNA damage response genes such as ATM, PARP1 and NBS1 have been identified recently [12], stimulating interest in determining if FA pathway inhibitors would selectively target tumor cells deficient in these genes.